Pinz Capital Management’s PAVmed PAVM Stock Holding History

Pinz Capital Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40	Closed	-$116K	–	321
2021 Q2	$116K	Sell	40 -43	-52%	-$102K	0.03%	190
2021 Q1	$166K	Buy	+83	New	+$125K	0.04%	115

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Pinz Capital Management's PAVM Position: Q3 2021 in Review

Pinz Capital Management sold out of PAVmed (PAVM) in Q3 2021, closing a stake of 40 shares — an estimated $116K sold.

Pinz Capital Management first reported a position in PAVM in Q1 2021 and held it in 2 quarters. The position peaked at $166K in Q1 2021. 107 funds tracked by Wall St. Rank hold PAVM as of Q3 2021.

Pinz Capital Management reported no remaining PAVmed position as of Q3 2021 after selling out during the quarter.
Pinz Capital Management sold 40 PAVmed shares in Q3 2021, an estimated $116K.
Pinz Capital Management first reported a position in PAVmed in Q1 2021 and held it in 2 quarters.
Pinz Capital Management's PAVmed position peaked at $166K in Q1 2021.
107 funds tracked by Wall St. Rank held PAVmed as of Q3 2021.

Based on Pinz Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.